The objective of this project is to create new tools able to take advantage of the high dimensionality of high throughput FCM (HT-FCM) data and to combine the result with genomics and proteomics. The methods proposed here will revolutionize the current basic academic and commercial tools in the scientific community. The integration of HT-FCM, genomics and proteomics data will provide a deeper understanding of specific immune cell behavior. The functional relationships identified will provide new knowledge enabling the elucidation of disease mechanisms, the prediction of therapeutic and vaccine outcome, and the development personalized medicine.
Co-project leader:
| Ryan | Brinkman | BC Cancer Research Centre |
Co-Applicants:
| Raphael | Gottardo | University of British Colombia |
| Larry | Greller | Biosystemix Ltd. |
| Richard | Leblanc | Université de Sherbrooke |
| Roland | Somogyi | Biosystemix Ltd. |
| Peter | Wilkinson | Université de Montréal |